Pfizer CEO sees a return to ‘regular’ globally on the finish of 2022

Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021.

John Thys | Pool | Reuters

Pfizer CEO Albert Bourla told CNBC on Wednesday that he expects life could return to normal for developed countries by the end of this year and the rest of the world by the end of 2022.

By that time, there should be enough Covid-19 vaccine doses for most world leaders to successfully inoculate their populations against the virus, Bourla said during an interview with Andrew Ross Sorkin at the CNBC Evolve Global Summit.

“I think the whole world will have enough volumes [of vaccine doses] by the end of 2022 to vaccinate, to protect everyone,” he said. “And I think that by the end of this year, the developed world will already be in this situation.”

Pfizer and German partner BioNTech hit the milestone of manufacturing 1 billion doses of their Covid vaccine last week, Bourla told CNBC. The companies expect to manufacture up to 3 million doses this year.

This is a developing story. Please check back for updates.

Comments are closed.